L

LYSOGENE

21 employees

Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

AAV vector
Biotechnology
Health Care
Gene Therapy
Central Nervous System Pathology
Medical
Pharmaceutical
Lysosomal Storage Disease

Date founded

2009

Funding rounds raised

Total raised

$22M

from 3 investors over 3 rounds

L

LYSOGENE raised $3.4M on December 24, 2021

Investors: European Investment Bank

L

LYSOGENE raised $22M on May 21, 2014

Investors: Sofinnova Ventures, Russia technology fund and Novo Holdings

FAQ